Detalhe da pesquisa
1.
Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex.
J Virol
; 91(17)2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28637753
2.
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.
Blood
; 128(10): 1396-407, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338099
3.
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.
Proc Natl Acad Sci U S A
; 111(7): 2722-7, 2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550301
4.
The role of phage display in therapeutic antibody discovery.
Int Immunol
; 26(12): 649-57, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135889
5.
Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
J Virol
; 87(5): 2693-706, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23255803
6.
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.
Proc Natl Acad Sci U S A
; 108(30): 12479-84, 2011 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21746897
7.
Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis.
J Lipid Res
; 54(10): 2924-32, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797850
8.
Molecular engineering of a therapeutic antibody for Blo t 5-induced allergic asthma.
J Allergy Clin Immunol
; 139(5): 1705-1708.e6, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923562
9.
Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.
Int J Mol Sci
; 13(3): 2618-2635, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22489114
10.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Int J Mol Sci
; 13(4): 4937-4948, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22606021
11.
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults.
Infect Dis Ther
; 11(5): 1999-2015, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058990
12.
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development.
Bioeng Transl Med
; 6(1): e10196, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532594
13.
Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza.
Viruses
; 12(12)2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348840
14.
Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Antivir Ther
; 14(7): 911-21, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19918095
15.
Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus.
Sci Rep
; 9(1): 9998, 2019 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292492
16.
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.
Nat Commun
; 10(1): 893, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792391
17.
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.
Virol J
; 5: 80, 2008 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18616831
18.
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
Virol J
; 5: 130, 2008 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957074
19.
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine.
Sci Rep
; 8(1): 18007, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573748
20.
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.
NPJ Vaccines
; 2: 31, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263886